ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 140 filers reported holding ANIKA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $353,000 | -36.9% | 8,665 | -19.6% | 0.02% | -45.9% |
Q4 2019 | $559,000 | -57.2% | 10,783 | -54.7% | 0.04% | -52.6% |
Q3 2019 | $1,305,000 | +129.8% | 23,782 | +69.9% | 0.08% | +25.8% |
Q2 2019 | $568,000 | +108.8% | 14,000 | +55.6% | 0.06% | +40.9% |
Q1 2019 | $272,000 | – | 9,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |